These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 26098302)
81. A New Rabbit-Skin Model to Evaluate Protective Efficacy of Tuberculosis Vaccines. Chen H; Liu X; Ma X; Wang Q; Yang G; Niu H; Li S; He B; He S; Dannenberg AM; Zhu B; Zhang Y Front Microbiol; 2017; 8():842. PubMed ID: 28567030 [No Abstract] [Full Text] [Related]
82. Immunogenicity and Protective Efficacy of a Multi-Antigen Nisa A; Pinto R; Britton WJ; Triccas JA; Counoupas C Vaccines (Basel); 2024 Aug; 12(9):. PubMed ID: 39340027 [TBL] [Abstract][Full Text] [Related]
83. Id3 and Bcl6 Promote the Development of Long-Term Immune Memory Induced by Tuberculosis Subunit Vaccine. Han J; Ma Y; Ma L; Tan D; Niu H; Bai C; Mi Y; Xie T; Lv W; Wang J; Zhu B Vaccines (Basel); 2021 Feb; 9(2):. PubMed ID: 33562631 [TBL] [Abstract][Full Text] [Related]
84. Enhancing immunogenicity of novel multistage subunit vaccine of Khademi F; Yousefi A; Derakhshan M; Najafi A; Tafaghodi M Iran J Basic Med Sci; 2019 Aug; 22(8):893-900. PubMed ID: 31579445 [TBL] [Abstract][Full Text] [Related]
85. Coating With Chitooligosaccharides Enhances the Cytokine Induction of Listeria ivanovii-Based Vaccine Strain. Zhang X; Su L; Huang H; Jiang M; Liu S; Li Y; Liu T; Zhou Y; Tang T; Mahdy SE; Wang C J Pharm Sci; 2019 Sep; 108(9):2926-2933. PubMed ID: 30995448 [TBL] [Abstract][Full Text] [Related]
86. Host protein glycosylation in nucleic acid vaccines as a potential hurdle in vaccine design for nonviral pathogens. Ozdilek A; Paschall AV; Dookwah M; Tiemeyer M; Avci FY Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1280-1282. PubMed ID: 31907319 [TBL] [Abstract][Full Text] [Related]
87. [Construction and Evaluation of a Novel TB Vaccine Candidate Based on Huang JL; Liu SJ; Su L; Wang C Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 48(6):814-818. PubMed ID: 29260512 [TBL] [Abstract][Full Text] [Related]
88. Balance between Protection and Pathogenic Response to Aerosol Challenge with Sulman S; Savidge BO; Alqaseer K; Das MK; Nezam Abadi N; Pearl JE; Turapov O; Mukamolova GV; Akhtar MW; Cooper AM Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34070048 [TBL] [Abstract][Full Text] [Related]
89. Design and Construction of a Cloning Vector Containing the Yaghoubi A; Aryan E; Zare H; Alami Sh; Teimourpour R; Meshkat Z Rep Biochem Mol Biol; 2016 Oct; 5(1):46-50. PubMed ID: 28070534 [TBL] [Abstract][Full Text] [Related]
90. Correction to: An Immunoinformatics-Based Study of Mycobacterium tuberculosis Region of Difference-2 Uncharacterized Protein (Rv1987) as a Potential Subunit Vaccine Candidate for Preliminary Ex Vivo Analysis. Arega AM; Dhal AK; Pattanaik KP; Nayak S; Mahapatra RK Appl Biochem Biotechnol; 2024 Apr; 196(4):2396. PubMed ID: 37552364 [No Abstract] [Full Text] [Related]
91. The Fusion Multistage Synthetic Peptides as the Best Candidates for New Tuberculosis Vaccine. Keikha M; Moghim S; Fazeli H; Nasr-Esfahani B Adv Biomed Res; 2018; 7():122. PubMed ID: 30211135 [No Abstract] [Full Text] [Related]
92. Age at Mycobacterium bovis BCG Priming Has Limited Impact on Anti-Tuberculosis Immunity Boosted by Respiratory Mucosal AdHu5Ag85A Immunization in a Murine Model. Damjanovic D; Khera A; Afkhami S; Lai R; Zganiacz A; Jeyanathan M; Xing Z PLoS One; 2015; 10(6):e0131175. PubMed ID: 26098423 [TBL] [Abstract][Full Text] [Related]
93. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis. Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436 [TBL] [Abstract][Full Text] [Related]
94. A multistage mycobacterium tuberculosis subunit vaccine LT70 including latency antigen Rv2626c induces long-term protection against tuberculosis. Liu X; Peng J; Hu L; Luo Y; Niu H; Bai C; Wang Q; Li F; Yu H; Wang B; Chen H; Guo M; Zhu B Hum Vaccin Immunother; 2016 Jul; 12(7):1670-7. PubMed ID: 26901244 [TBL] [Abstract][Full Text] [Related]
95. A High Throughput Screening Assay for Anti-Mycobacterial Small Molecules Based on Adenylate Kinase Release as a Reporter of Cell Lysis. Forbes L; Ebsworth-Mojica K; DiDone L; Li SG; Freundlich JS; Connell N; Dunman PM; Krysan DJ PLoS One; 2015; 10(6):e0129234. PubMed ID: 26098625 [TBL] [Abstract][Full Text] [Related]
96. Innate signaling by mycobacterial cell wall components and relevance for development of adjuvants for subunit vaccines. Tima HG; Huygen K; Romano M Expert Rev Vaccines; 2016 Nov; 15(11):1409-1420. PubMed ID: 27206681 [TBL] [Abstract][Full Text] [Related]
97. Boosting BCG-primed mice with chimeric DNA vaccine HG856A induces potent multifunctional T cell responses and enhanced protection against Mycobacterium tuberculosis. Ji P; Hu ZD; Kang H; Yuan Q; Ma H; Wen HL; Wu J; Li ZM; Lowrie DB; Fan XY Immunol Res; 2016 Feb; 64(1):64-72. PubMed ID: 26111521 [TBL] [Abstract][Full Text] [Related]
98. Mycobacterium tuberculosis virulence: insights and impact on vaccine development. Delogu G; Provvedi R; Sali M; Manganelli R Future Microbiol; 2015; 10(7):1177-94. PubMed ID: 26119086 [TBL] [Abstract][Full Text] [Related]
99. Evasion of Innate and Adaptive Immunity by Mycobacterium tuberculosis. Goldberg MF; Saini NK; Porcelli SA Microbiol Spectr; 2014 Oct; 2(5):. PubMed ID: 26104343 [TBL] [Abstract][Full Text] [Related]
100. B Cells and Programmed Death-Ligand 2 Signaling Are Required for Maximal Interferon-γ Recall Response by Splenic CD4⁺ Memory T Cells of Mice Vaccinated with Mycobacterium tuberculosis Ag85B. Riccomi A; Palma C PLoS One; 2015; 10(9):e0137783. PubMed ID: 26379242 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]